Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Magdy M, Abdelquader"'
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 186:85-104
Autor:
Ebtessam A. Essa, Gamal M. El Maghraby, Toka Tarek Elebyary, Amal Elkordy, Magdy M Abdelquader
Sustaining and controlling the rate of drug release is essential in pharmaceutical technology. It can reduce the number of units administered by the patient with subsequent improvement in patient compliance. These technologies can allow controlled li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a03102019290140754e14f938991032b
Publikováno v:
AAPS PharmSciTech. 22
Development of fixed dose combinations is growing and many of these drug combinations are being legally marketed. However, the development of these requires careful investigation of possible physicochemical changes during co-processing. This requires
Publikováno v:
AAPS PharmSciTech. 22(2)
Development of fixed dose combinations is growing and many of these drug combinations are being legally marketed. However, the development of these requires careful investigation of possible physicochemical changes during co-processing. This requires
Publikováno v:
AAPS PharmSciTech. 20(1)
Olmesartan medoxomil (Olm) and hydrochlorothiazide (HCTZ) are fixed dose combination (FDC) for treatment of hypertension. They have hydrogen bonding sites and may interact during co-processing. The consequences of such interaction are not clear. This